Magellan Health Services, Inc. (MGLN)

Check out top investors' recommendation for MGLN
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Magellan Health Services, Inc. engages in the specialty managed healthcare business in the United States. The company, through its contracted network of third-party treatment providers, offers managed behavioral healthcare services, including outpatient programs, such as counseling or therapy; intermediate care programs comprising intensive outpatient programs and partial hospitalization services; and inpatient treatment and crisis intervention services. It also provides radiology benefits management services, such as the delivery of diagnostic imaging and other therapeutic services through contracts with health plans and insurance companies, and governmental agencies. In addition, the company offers specialty pharmaceutical management services, including contracting and formulary optimization programs; specialty pharmaceutical dispensing operations; and medical pharmacy management programs. Its specialty pharmaceutical management services are provided under contracts with health plans, insurance companies, employers, and governmental agencies to manage specialty drugs used in the treatment of conditions, such as cancer, multiple sclerosis, hemophilia, infertility, rheumatoid arthritis, chronic forms of hepatitis, and other diseases. Further, the company provides Medicaid administration services comprising network management, formulary and rebate management, point-of-sale claims processing systems and administration, clinical prior authorization, and drug utilization review under contracts with health plans and employers, as well as public sector clients sponsoring Medicaid and other state benefit programs. It serves health plans, insurance companies, employers, labor unions, and various governmental agencies. Magellan Health Services, Inc. was founded in 1969 and is based in Avon, Connecticut.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Jason Gurda Leerink Swann Llc Buy   Dec 01, '17     105.00  Dec 01, '18  N/A 
David Windley Jefferies & Co. Buy   Oct 13, '17     94.00  Oct 13, '18  N/A 
Donald Hooker Morgan Stanley Buy   Sep 20, '17     89.00  Sep 20, '18  N/A 
Ana Gupte Dowling & Partners Securities, LLC Buy   Jun 23, '17     73.00  Jun 23, '18  N/A 
Greg Poole Deutsche Bank Securities Buy   Dec 18, '13   56.91    Dec 18, '14  4.32% 
Scott Fidel Deutsche Bank Securities Buy   Oct 25, '13   59.93  65.00  Oct 25, '14  -3.79% 
Carl Mcdonald Citi Sell   Jul 30, '13   56.41    Jul 30, '14  -3.42% 
Carl Mcdonald Citi Buy   Dec 30, '12   49.00  58.00  Dec 30, '13  18.37% 
Scott Fidel Deutsche Bank Securities Buy   Dec 11, '12   49.94  61.00  Dec 11, '13  22.15% 
Matthew Borsch Goldman Sachs Sell   Oct 28, '12   50.15  51.00  Oct 28, '13  -1.69% 
Scott Fidel Deutsche Bank Securities Buy   Jul 29, '12   55.50  64.00  Jul 29, '13  6.81% 
Scott Green BofA Merrill Lynch Sell   Dec 07, '11   49.88  44.00  Dec 07, '12  11.79% 
Scott Fidel Deutsche Bank Securities Buy   May 01, '11   51.79  62.00  May 01, '12  -15.33% 
Scott Green BofA Merrill Lynch Sell   Apr 10, '11   49.56  50.00  Apr 10, '12  5.19% 
Matthew Borsch Goldman Sachs Sell   Feb 03, '11   49.14  48.00  Feb 03, '12  2.32%